Monitoring of Patient With Diabetes Mellitus

Widodo Widodo

Abstract


Diabetes mellitus is a disease characterized by hyperglycemia, which is caused by impaired insulin secretion, impaired insulin action, or both. Chronic hyperglycemia will lead to dysfunction and damage to various organs, such as the eyes, kidneys, nerves, heart, and blood vessels.

This paper discusses the monitoring of patients with diabetes mellitus according to the laboratory tests, to know when the results of therapy has reached the optimum point as well as the prevention of complications that can occur.

 


Keywords


Diabetes mellitus, laboratory tests, complications

Full Text:

PDF

References


Masharani, U. Diabetes Mellitus and Hypoglicemia. on Current Medical Diagnosis & Treatment. 15th ed. The McGraw-Hill Companies, Inc. 2011. p. 1140 – 76.

Powers, A. C. Diabetes Mellitus, on Harrison’s Principles of Internal Medicine. Vol II, 17th ed. McGraw-Hill Medical, New York. 2008. p. 2275 – 2304.

Direktorat Bina Farmasi Komunitas dan Klinik. Pharmaceutical Care untuk Penyakit Diabetes Melitus, Departemen Kesehatan RI. 2005. on www.binfar.depkes.go. id.

IDF. IDF Diabetes Atlas; 5th ed. International Diabetes Federation. 2012.

Bender, D.A. Gluconeogenesis & the Control of Blood Glucose; on Harper’s Illustrated Biochemistry; 28th ed. McGraw-Hill. 2009. p. 165 – 173.

ADA. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2013. 36, Supp 1 : S67 – 74

Imran, A.; et al; 2013; Targets for Glycemic Control; Can J Diabetes; vol. 37; supp. 1; p. S31 – S34.

Inzucchi, S. E., R.M. Bergenstal, J.B. Buse, M. Diamant, E. Ferrannini, M. Nauck, et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Diabetes Care. 2012. 35(6) : 1364-1379.

Ceska, R. Clinical Implications of Metabolic Syndrome: Diab. & Vasc Dis Res. 207. Vol. 4; Supp 2.

IDF. The IDF Consensus Worldwide Definition of The Metabolic Syndrome. IDF Communication. 2006.

Arguedas. J.A., M.I. Perez, J.M. Wright. Blood Pressure Targets for Hypertension in People with Diabetes Mellitus. Cochrane Datab Syst Rev. 2013. No. 10.

Schulze, M.B. and F.B. Hu. Primary Prevention of Diabetes: What Can Be Done and How Much Can Be Prevented?. Annu Rev Public Health. 2005. 26 : 445-467.

ADA. Standards of Medical Care in Diabetes – 2013. Diabates Care. 2013. 36, Supp 1: S11 – 66

Eko, V. Terapi Diabetes Mellitus. CDK. 2011. edisi 182 : 13 – 20.

Kennedy, M.N. Pancreatic Hormones & Antidiabetic Drugs. on Katzung Basic and Clinical Pharmacology. 12th ed. The McGraw-Hill Med. 2011. p. 743-768.

Bosi, D. F. Dotta, Y. Jia, M. Goodman. Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2009. 11(5) : 506-515.

Ji, L.N., C.Y. Pan, J.M. Lu, H. Li, Q. Li, Q.F. Li, Y.D. Peng et al., Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study. Cardiovascular Diabetology. 2013. 12 (118).

Berard, L.D., I. Blumer, R. Houlden, D. Miller, V. Woo. Monitoring Glycemic Control. Can J Diabetes. 2013. 37, Supp. 1: S35 – S39.

Lu, Z.X., K.Z. Walker, K. O’Dea, K.A. Sikaris, J.E. Shaw. A1C for Screening and Diagnosis of Type 2 Diabetes in Routine Clinical Practice: Diabetes Care. 2010. 33(4) : 817-819.

Stone, J.A., D. Fitchett, S. Grover, R. Lewanczuk, P. Lin. Vascular Protection in People with Diabetes. Can J Diabetes. 2013. 37, supp. 1 : S100 – S104.

Mancini, G.B.J.; Dyslipidemia. Can J Diabetes. 2013. 37, supp. 1 : S110 – S116.

McFarlane, P., R.E. Gilbert, L. MacCallum, P. Senior. Chronic Kidney Disease in Diabetes. Can J Diabetes. 2013. 37, supp. 1 : S129 – S136.

Boyd, S.R., A. Advani, F. Altomare, F. Stockl. Retinopathy. Can J Diabetes. 2013. 37, supp. 1 : S137 – S141.

Bril, V.B., B. Perkins, C. Toth. Neuropathy. Can J Diabetes. 2013. 37, supp. 1 : S142 – S144.

Bowering, K. and J.M. Embil . Foot Care. Can J Diabetes. 2013. 37, supp. 1 : S145 – S149.

Brock, G. and W. Harper. Erectile Dysfunction. Can J Diabetes. 2013. 37, supp. 1 : S150 – S152.




DOI: http://dx.doi.org/10.30742/jikw.v3i2.23

Refbacks

  • There are currently no refbacks.


Copyright (c) 2014 Widodo Widodo

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Jurnal Ilmiah Kedokteran Wijaya Kusuma is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License